Alteplase

Alternative Names: Activase

Alteplase is a clot-busting medication (tPA) used in the treatment of acute ischemic stroke. It works by dissolving the clot and restoring blood flow to the brain, which can improve recovery if given quickly. The drug is most effective when administered within 4.5 hours of symptom onset, after imaging confirms there is no hemorrhage. The main risk is bleeding, including intracranial hemorrhage, so strict eligibility criteria must be met before use. When appropriately administered, alteplase significantly increases the chance of a good neurological outcome.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Alteplase

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the provided review, Alteplase (tPA) appears to be an effective treatment for acute ischemic stroke when administered within a specific time window. The medication can significantly improve patient outcomes, but its use requires careful patient selection due to the substantial risk of serious bleeding complications. The effectiveness of the treatment depends on prompt administration and strict adherence to eligibility criteria.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
1.0
1 = Very Expensive 5 = Very Affordable

1.0

Very Expensive
Relief Speed
4.0
1 = No Relief 5 = Immediate Relief

4.0

Fast Relief
Side Effects
2.0
1 = Intolerable Effect 5 = No Effect

2.0

Severe Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the provided review, Alteplase (tPA) appears to be an effective treatment for acute ischemic stroke when administered within a specific time window. The medication can significantly improve patient outcomes, but its use requires careful patient selection due to the substantial risk of serious bleeding complications. The effectiveness of the treatment depends on prompt administration and strict adherence to eligibility criteria.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
Alteplase (tPA) is a clot-dissolving medication used for acute ischemic stroke that can significantly improve outcomes if given quickly. Timing is everything here—treatment is recommended within 4.5 hours of symptom onset, with the greatest benefit when it’s given as early as possible (ideally within 3 hours). When we talk about “time of onset,” it’s usually based on when the patient was last seen normal, especially if no one actually witnessed the stroke happen. I’m very careful to make sure patients meet all eligibility criteria, because while tPA can be very effective, there’s a real risk of serious bleeding, including intracranial hemorrhage. Careful patient selection is key to getting the benefit while minimizing harm.
#VeryExpensive #FastRelief #SevereEffect #First-line #Rescue/EmergencyUse
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All